“The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment. Thus, cannabinoids may be considered for FMS treatment.”
“The findings of this study add to the growing body of evidence that easier access to cannabis for patients with pain may reduce opioid use and partially offset expenditures for both public and private drug plans.”
“Over time, individuals who continued consuming cannabis within this longitudinal study reported lower pain severity and pain interference scores, as well as improved quality of life and general health symptoms scores.”
Some 30 percent of migraine patients have used cannabis to mitigate migraine pain. Among these users, 82 percent reported it to be effective at providing migraine relief.
Investigators reported a “strong positive association” between subjects’ frequency of cannabis use and self-reported improvements in pain, health-care utilization, and overall health-related quality of life.
“This feasibility trial demonstrated that a metered-dose cannabis inhaler delivered precise and low THC doses [that] produced a dose-dependent and safe analgesic effect.”
“Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.”
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to study.